Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Wegovy
Wegovy
Novo Nordisk shares rise on fourth-quarter profit beat, Wegovy sales jump
CNBC
Wed, 02/5/25 - 10:42 pm
Novo Nordisk
Wegovy
earnings
Ozempic-Like Drugs May Hold Risks For Surgical Patients, Officials Say
Forbes
Fri, 01/31/25 - 10:59 am
surgery
GLP-1 agonists
Novo Nordisk
Eli Lilly
Ozempic
Wegovy
Zepbound
Mounjaro
Large study of Novo, Lilly weight loss drugs shows decrease in risk of Alzheimer's
Fierce Pharma
Tue, 01/21/25 - 07:13 pm
Novo Nordisk
Eli Lilly
GLP-1 agonists
Wegovy
Ozempic
Zepbound
Mounjaro
Alzheimer's disease
arthritis
Novo Nordisk touts 'superior' weight loss results in study of high-dose Wegovy
Fierce Pharma
Fri, 01/17/25 - 11:34 am
Novo Nordisk
obesity
semaglutide
Wegovy
Eli Lilly
Zepbound
clinical trials
Ozempic tops new Medicare price negotiation list
Pharmaphorum
Fri, 01/17/25 - 11:10 am
Novo Nordisk
Ozempic
Wegovy
Rybelsus
HHS
Inflation Reduction Act
Medicare
Use of diabetes and anti-obesity drugs surges nationwide
Axios
Fri, 01/3/25 - 10:07 am
obesity
diabetes
Eli Lilly
Novo Nordisk
Ozempic
Wegovy
Mounjaro
Zepbound
GLP-1 agonist
UK's private obesity drug market chooses Lilly's Mounjaro over Wegovy
Yahoo/Reuters
Fri, 12/13/24 - 11:43 am
Eli Lilly
Mounjaro
Novo Nordisk
Wegovy
UK
obesity
Lilly’s Zepbound beats Novo’s Wegovy in high-stakes obesity drug trial
BioPharma Dive
Wed, 12/4/24 - 11:02 am
Eli Lilly
Zepbound
Novo Nordisk
Wegovy
clinical trials
weight loss
obesity
Novo Nordisk India execs urge early Wegovy launch as weight-loss rival looms
Pharma Live
Tue, 12/3/24 - 11:36 am
Novo Nordisk
India
Wegovy
Eli Lilly
Zepbound
Health Canada approves Novo Nordisk's obesity drug to reduce risk of non-fatal heart attack
MSN
Wed, 11/27/24 - 09:57 pm
Novo Nordisk
Wegovy
Canada
Health Canada
obesity
Biden proposes Medicare and Medicaid cover weight loss drugs
Axios
Tue, 11/26/24 - 09:51 am
Joe Biden
Medicare
Medicaid
obesity
Novo Nordisk
Eli Lilly
Zepbound
Wegovy
Ozempic
Novo’s Wegovy Launched in China at a Fraction of US Price
BioSpace
Mon, 11/18/24 - 11:28 am
Novo Nordisk
Wegovy
Cina
weight loss
GLP-1 agonists
Survey Finds Most GLP-1 Users Discontinue Drug Before Reaching Goal Weight
Xtalks
Fri, 11/15/24 - 11:27 am
Omada Health
GLP-1 agonists
obesity
weight loss
Novo Nordisk
Eli Lilly
Ozempic
Zepbound
Mounjaro
Wegovy
FDA adds aspiration warning to Ozempic, Mounjaro and other GLP-1 labels
Beckers Hospital Review
Wed, 11/6/24 - 08:01 pm
FDA
warnings
aspiration
Ozempic
Wegovy
Saxenda
Mounjaro
Novo Nordisk
Eli Lilly
Novo Nordisk Q3 earnings: Wegovy sales soar 79% year-over-year
Yahoo Finance
Wed, 11/6/24 - 11:44 am
Novo Nordisk
Wegovy
earnings
States slow to cover GLP-1s for weight loss
Axios
Wed, 11/6/24 - 11:37 am
Medicaid
GLP-1 agonists
Novo Nordisk
Eli Lilly
Wegovy
Zepbound
Wegovy reduces all-cause admissions: 3 study findings
Beckers Hospital Review
Mon, 11/4/24 - 11:19 am
Novo Nordisk
Wegovy
hospital admissions
clinical trials
Novo takes big step toward ending Ozempic, Wegovy shortages
BioPharma Dive
Wed, 10/30/24 - 08:48 pm
Novo Nordisk
drug shortages
obesity
Ozempic
Wegovy
Weight-loss drugs didn't curb health costs within two years
Reuters
Thu, 10/24/24 - 11:11 am
Novo Nordisk
Eli Lilly
Wegovy
Zepbound
obesity
FDA’s GLP-1 decision kicks off ‘unprecedented’ tussle over shortage
Pharma Voice
Mon, 10/21/24 - 09:37 am
FDA
GLP-1 agonists
Ozempic
Wegovy
Novo Nordisk
drug shortages
Eli Lilly
Zepbound
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »